₹1.42
(Market cap
₹107 Cr
Revenue (TTM)
₹86 Cr
P/E Ratio
52.1
P/B Ratio
2.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹2 Cr
-
ROE
1 %
-
ROCE
5.2 %
-
Industry P/E
33.99
-
EV/EBITDA
20.5
-
Debt to Equity
0.6
-
Book Value
₹37.7
-
EPS
₹1.8
-
Face value
10
-
Shares outstanding
13,175,000
10 Years Aggregate
CFO
₹24.44 Cr
EBITDA
₹46.87 Cr
Net Profit
₹9.64 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Concord Drugs
| -1.6 | 19.4 | -0.6 | 44.1 | 31.2 | 24.4 | 3.2 |
|
BSE Healthcare
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Concord Drugs
| 117.3 | -32.8 | 83.5 | 1.2 | 46.0 | 53.2 | -33.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Concord Drugs
|
81.1 | 106.9 | 86.1 | 2.1 | 5.2 | 4.9 | 52.1 | 2.2 |
| 7,106.5 | 17,765.6 | 2,432.1 | 169.6 | 8.7 | 20.8 | 104.7 | 19.6 | |
| 2,517.2 | 19,125.3 | 2,287.3 | 678.1 | 31.4 | 19.7 | 28.7 | 5.1 | |
| 2,079.5 | 12,740.0 | 1,479.1 | 198.6 | 18.6 | 30.3 | 64 | 15.8 | |
| 1,314.8 | 18,252.8 | 3,229.7 | 666.9 | 26.6 | 18.8 | 28.3 | 4.5 | |
| 2,408.9 | 38,730.8 | 4,147.8 | 709.5 | 22.3 | 19.1 | 54.6 | 9.3 | |
| 4,703.8 | 21,500.8 | 2,569.8 | 735.2 | 34.4 | 19.2 | 29.2 | 4.9 | |
| 5,670.5 | 9,412.3 | 1,432.9 | 356.9 | 30.8 | 58.2 | 26.4 | 15.3 | |
| 903.8 | 17,685.5 | 1,682.5 | 273.5 | 21.0 | 11.1 | 59.5 | 6.6 | |
| 1,019.9 | 9,406.7 | 5,004.4 | 635.3 | 14.5 | 19.8 | 15.3 | 2.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Concord Drugs
Manufacture of pharmaceuticals, medicinal chemical and botanical products
-
Incorporated
1995
-
Chairman
S Nagi Reddy
-
Managing Director
S Nagi Reddy
-
Headquarters
Rangareddy Dist, Telangana
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Concord Drugs
What is the current share price of Concord Drugs Ltd Today?
The share price of Concord Drugs Ltd is ₹81.13 (BSE) as of 28-Aug-2026 IST. Concord Drugs Ltd has given a return of 31.17% in the last 3 years.
What is the current PB & PE ratio of Concord Drugs Ltd?
The P/E ratio of Concord Drugs Ltd is 52.12 times as on 28-Aug-2026, a 53 premium to its peers’ median range of 33.99 times.
The P/B ratio of Concord Drugs Ltd is 2.15 times as on 28-Aug-2026, a 58 discount to its peers’ median range of 5.06 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
92.45 |
0.91 |
2024 |
74.45 |
1.04 |
2023 |
25.95 |
0.82 |
2022 |
15.90 |
0.89 |
2021 |
7.74 |
0.95 |
What is the 52 Week High and Low of Concord Drugs Ltd?
The 52-week high and low of Concord Drugs Ltd are Rs 92.52 and Rs 56.17 as of 29-Aug-2026.
What is the market cap of Concord Drugs Ltd?
Concord Drugs Ltd has a market capitalisation of ₹ 107 Cr as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Concord Drugs Ltd?
Before investing in Concord Drugs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.